Cargando…
A Case of Primary Biliary Cirrhosis That Progressed Rapidly after Treatment Involving Rituximab
Primary biliary cirrhosis (PBC) is a progressive liver disease for which limited therapies are recommended. Rituximab, an anti-CD20 monoclonal antibody, is expected to be a useful therapeutic regimen for PBC. Previous studies indicated biochemical and immunological improvement in PBC after rituximab...
Autores principales: | Tajiri, Kazuto, Tsuneyama, Koichi, Miyazono, Takahiro, Kawai, Kengo, Minemura, Masami, Sugiyama, Toshiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656669/ https://www.ncbi.nlm.nih.gov/pubmed/23687488 http://dx.doi.org/10.1159/000351173 |
Ejemplares similares
-
Rituximab Therapy for Severe Cutaneous Leukocytoclastic Angiitis Refractory to Corticosteroids, Cellcept and Cyclophosphamide
por: El-Reshaid, Kamel, et al.
Publicado: (2013) -
Granulysin-Bearing Cells in the Skin Lesions of Acute Graft-versus-Host Disease: Possible Mechanisms for Hypohidrosis in Graft-versus-Host Disease
por: Furudate, Sadanori, et al.
Publicado: (2013) -
Agraphia Caused by Left Thalamic Hemorrhage
por: Osawa, Aiko, et al.
Publicado: (2013) -
Posterior Reversible Leukoencephalopathy Syndrome Associated with Pazopanib
por: Foerster, Robert, et al.
Publicado: (2013) -
Chronic Portal-Systemic Shunt Encephalopathy in a Hemodialysis Patient Treated with Balloon-Occluded Retrograde Transvenous Obliteration
por: Yasukawa, Ryota, et al.
Publicado: (2013)